FDA Approves Initiation of IGC’s Cannabinoid Trial on Alzheimer’s Patients

POTOMAC, Md.–(BUSINESS WIRE)–India Globalization Capital (IGC or the Company) (NYSE American: IGC) announced today that on July 30, 2020, the U.S. Food and Drug Administration (FDA) notified IGC th…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *